Press / Medias

Cornell patent deal helps LNC ramp-up microbiome therapeutics strategy

Dec 17, 2018

A new patent licencing deal between Cornell and LNC Therapeutics will help the French biotech become the ‘must have’ partner for research and product development relating to the Christensenella strain, says the company’s CEO.

Clic here to read the full article

 

 

In the same category

Press / Medias

LNC Therapeutics selected by BNP Paribas for its innovative approach to beat obesity

Nov 12, 2019

more +
Press / Medias

Avec plus de 140 millions d’euros levés, les startups ne ratent pas leur rentrée

Sep 6, 2019

more +
Press / Medias

LNC Therapeutics raises €6.2 million for the clinical development of new generation gut microbiome...

Sep 5, 2019

more +

LNC Therapeutics © 2019 - all rights reserved terms and conditions